- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 309.56M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 308.53M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 293.12M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $77K |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $231K |
| Capex | Q1 2026 · Mar 31, 2026 | $865K |
| Capex restated | Q1 2026 · Mar 31, 2025 | $2.36M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $8.49M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $8M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $219.95M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $221.47M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $362K |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $362K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $39M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $37.41M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $90.94M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $99.02M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $165.11M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $176.82M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $67.68M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $79.93M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $458.16M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $458.36M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $102.44M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $110.11M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $549.1M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $557.38M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.05 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$8M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$12.27M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $11.52M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $12.24M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $34.6M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $34.68M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $30.94M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $29.62M |
| Revenue | Q1 2026 · Mar 31, 2026 | $65.54M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $64.3M |